The Th1−Th2 paradigm was maintained until some years ago when a third subset of CD4+ effector Th cells, named Th17 cells, was identified. 5, 6 From mice to men: the discovery of Th17 cells
Murine Th17 cells
Although the existence of IL-17 as a product of activated CD4+ T cells has been known for more than ten years, only recently was the existence of Th17 as a distinct subset recognized. 5, 6 The breakthrough leading to the discovery of the Th17 lineage came from murine models of genes. 4 However, this initial concept of Th1 association to autoimmune disorders required an adjustment with the unexpected discovery that mice deficient in IFN-γ or IFN-γ receptor were not resistant to EAE but were actually more susceptible to central nervous system autoimmunity. [7] [8] [9] Moreover, the link with IL-12 in these diseases was called into question by the discovery that a new IL-12 family member, IL-23, shares with IL-12 the p40 subunit, the heterodimer of IL-12 being composed of p40 and p35, and that of IL-23 being composed of p40 and p19. 5 IL-23 shares with IL-12 also a chain of its receptor, the IL-12 receptor being composed of IL-12Rβ1 and IL-12Rβ2
chains, and that of IL-23 being composed of IL-12Rβ1 and IL-23 receptor (IL-23R) chains. After this discovery, it was found that EAE and CIA did not develop in mice deficient in IL-23p19 subunit or IL-23R chain, whereas they could develop in those deficient in IL-12p35 subunit or IL-12Rβ2 chain, suggesting that at least in these models IL-23 but not IL-12 is critically linked to autoimmunity. 6, 10, 11 Based on these and other findings, a new role for Th17 cells in immunopathology and the distinct origin of Th1 and Th17 under differential IL-12 or IL-23 conditioning was proposed. 6, 10 More recently, however, a completely different pathway of murine Th17 origin has been described. Although IL-23 appeared to be required for Th17-induced immunopathology, different groups independently demonstrated that transforming growth factor (TGF)-β was required for initiation and that IL-6 was a critical co-factor for Th17 differentiation. [12] [13] [14] Of note, the Th17-polarizing cytokine TGF-β was already known for its ability to promote the development of Foxp3+ Treg cells, but only in absence of IL-6. 14 Moreover, IFN regulatory factor 4 has been shown to be essential for the Th17 phenotype, by acting via the induction of IL-21, another cytokine which contributes to the induction, amplification, and stabilization of Th17 cells.
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Finally, the presence in culture medium of natural agonists for aryl hydrocarbon receptor seem also to be critical for optimal differentiation of Th17 cells. 16 Murine Th17 express a master transcription factor different from Th1 and Th2 cells, an orphan receptor known as retinoic acid-related orphan receptor (ROR)γt. 17 A second orphan receptor, named as RORα has also been found to contribute to the development of murine Th17 cells. 18 The signal transducer and activator of transcription (STAT)3 transcription factor is also essential for the murine Th17 development, although whether it acts directly or through the activation of RORγt is still unclear. 19 The distinctive cytokine of murine and therefore may induce and/or maintain a chronic inflammatory process. However, because of their unique ability to recruit neutrophils, the main protective function of Th17 cells appears to be the clearance of extracellular pathogens, including fungi. 21 Nevertheless, the major emphasis on the pathophysiology of murine Th17 cells was placed on their determinant or even exclusive pathogenic role on models of autoimmunity. This concept was immediately extrapolated to human disorders which are considered as equivalent to the above mentioned murine models, such as multiple sclerosis, rheumatoid arthritis and IBD, 22 but also to psoriasis and contact dermatitis. 23 Therefore, Th17 cells were thought to be the pathogenic cells in virtually all chronic inflammatory disorders, where the effect Th1 cells, that had been shown to be important in hundreds of previous studies, was underscored or even seen as protective against the Th17-mediated inflammation. 24 This sort of iconoclastic fury against the past dogma was well expressed in a commentary, which got the idea from the expression used in the age of monarchy "Le Roi est mort; vive le Roi", to mark the passing of eras ushering out one regime while introducing another. 25 For personal use only. on April 30, 2017 . by guest www.bloodjournal.org From
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Human Th17 cells
Several studies had already reported the expression of IL-17A mRNA and/or protein in biological fluids or tissues of different human inflammatory disorders, [26] [27] [28] [29] [30] [31] but no clear evidence on the existence, the phenotype and the functional activity of human Th17 cells was given until they were extensively investigated by different groups. [32] [33] [34] [35] Acosta-Rodriguez et al. 32, 34 isolated human memory Th17 cells from the CD4+ T cell fraction of peripheral blood of healthy subjects expressing the CC chemokine receptor (CCR) 6. Among CCR6+ T cells, the CCR4+ subset had copious production of IL-17A, but not IFN-γ, whereas the CXCR3+ subset mainly produced IFN-γ, and low IL-17A. CCR6+CCR4+ Th17 cells also expressed the human ortholog of mouse RORγt (RORC variant 2) and were found to contain the majority of Candida albicans-specific memory T cells, whereas the majority of Mycobacterium tuberculosis PPD-specific memory CD4+ T cells were found to be contained in the CCR6+CXCR3+ subset. By using a different experimental approach, Annunziato et al. 33 generated T-cell clones from the inflamed or apparently healthy gut of patients with Crohn's disease (CD), as well as from the peripheral blood of CD patients or healthy subjects. The Th17 clones that were generated in addition to Th1 and Th2 clones from both peripheral blood and gut tissue, were found to express RORC, CCR6, CCR4 and the IL-23R. When CCR6+ cells were isolated from either peripheral blood or tonsil of healthy subjects, virtually all Th17 cells were found to be contained in the CCR6+ fraction, whereas Th1 cells could be recovered from either the CCR6+ or the CCR6-fraction. The CCR6+ fraction also contained significantly higher amounts of RORC and IL-23R mRNA, supporting the concept that CCR6 is an important marker for human Th17 cells. Finally, Wilson et al. 35 demonstrated that human Th17 cells express IL-17A, IL-17F, IL-22, IL-26, IFN-γ, the chemokine CCL20, the transcription factor RORγt and the
IL-23R.
From men to mice: Th17 plasticity to Th1 cells and its reflection on pathogenicity
Human Th17 cells can be induced in vitro to produce IFN-γ
After the discovery of CCR6 as a major chemokine receptor of human Th17 cells, 32, 33 the demonstration of CCR6 expression even on murine Th17 cells was established in an animal model of RA. 36 In this study, it was also shown that synoviocytes produce CCL20 and that CCR6 blocking substantially inhibited mouse arthritis, 36 thus supporting the concept of a similarity between murine and human Th17 cells. However, in our study on human Th17 clones mentioned above 33 some features clearly different from, or even incompatible with, the Th17 paradigm established in mice were reported. [12] [13] [14] For example, many human Th17 clones also produced IFN-γ, that were named as Th17/Th1. This discrepancy could obviously be due to the different experimental conditions used to investigate Th17 cells in mice and humans. However, even ex-vivo studies performed in humans clearly demonstrated the existence in both peripheral blood and gut tissue of Th17/Th1 cells. 33 Second, both Th17 and Th17/Th1 clones not only expressed the IL-23R and RORC, but also the IL-12Rβ2 chain and the Th1-related transcription factor T-box expressed in T cells (T-bet). 33 Finally and most importantly, stimulation of human Th17 clones in presence of IL-12 down-regulated RORC and up-regulated T-bet and enabled these cells to produce IFN-γ in addition to IL-17A. By contrast, human Th1 clones could never be induced to produce IL-17A. These findings allowed us to suggest the existence of a developmental relationship between human Th17 and Th1 cells and,
more importantly, to demonstrate the plasticity of human Th17 cells, thus providing the novel concept that these cells can shift to the Th1 profile, whereas Th1 cells seem unable to shift to Th17. 33 
Either murine Th17 or Th1 cells can exhibit pathogenicity
The demonstration of a potential plasticity of human Th17 cells to Th1 cells was of great importance with regard to the controversial issue of the respective role of the two effector cell types in the pathogenesis of murine and human autoimmune, as well as of other chronic inflammatory, 6 ,10 a series of well performed studies has strongly challenged this possibility.
Therapeutic administration of a small interfering RNA specific for T-bet significantly improved the clinical course of established EAE by limiting the differentiation of autoreactive Th1 and inhibiting pathogenic Th17 cells through the regulation of IL-23R. 37 In Helicobacter hepaticus-induced colitis IFN-γ, but not IL-17, was the crucial T-cell effector cytokine when Treg cells were absent. 38 Th17
can be pathogenic in certain forms of EAE (those characterized by granulocyte infiltration), whereas Th1 cells are mainly responsible for the EAE models characterized by prevalent mononuclear cell infiltration, where Th17 cells do not seem to play any pathogenic role. 39 In the murine model of autoimmune disorder known as proteoglycan-induced arthritis, Th1 cells, but not Th17 cells, are pathogenic. 40 Either Th1 or Th17 cells have been found to be pathogenic in experimental autoimmune uveitis. 41 Neither IL-17A, not IL-17F, contribute vitally to autoimmune neuroinflammation in mice. 42 Obviously, it should be reminded that Th17 cells do not produce only IL-17A and IL-17F but also other cytokines such as IL-22, which has been found to be responsible for tissue damage. 43 The contrast between these findings and those derived from genetically deficient mice may probably be explained by the heterodimeric structure of the proteins of the IL-12 family. 44 Indeed, the recent discovery of IL-35, a cytokine with immunosuppressive activity produced by Treg cells, which is composed by the association of p35 and EBI3 subunits, allow to suggest that p35-/-mice lack not only IL-12 but also IL-35. 45, 46 Thus the opposing activities of these cytokines (IL-12 versus IL-35) further complicate the analysis, as the loss of one may mitigate the loss of the other, and therefore explain the higher EAE and CIA susceptibility of p35-/-mice.
Even murine Th17 cells exhibit plasticity to Th1 cells both in vitro and in vivo
Based on this impressive series of new data, [37] [38] [39] [40] [41] [42] 
types of Th1 cells. In conclusion, it was certainly not correct to say: "Le Roi est mort; vive le Roi"; 25 at the most we can accept the formula: "Le Roi est encore vivant; vive le nouveau Prince".
Of mice and men: their Th17 cells have a different origin
The role of TGF-β in human Th17 differentiation is still controversial
While it is widely accepted that murine Th17 cells originate from naïve CD4+ T cells in the presence of IL-6 and TGF-β, and their development is then stabilized and/or amplified by IL-23 and IL-21 (see also above), several studies have denied the role of TGF-β in human Th17 cell differentiation. 34, 35, 52 The differences between humans and mice were attributed to the difficulty to ensure a truly naïve T-cell population in humans. Accordingly, van Beelen et al. 53 found that the combined activity of IL-1α or IL-1β and IL-23 was required for the enhancement of human Th17 memory T cells, whereas under these or even other conditions the differentiation of human naïve T cells from adult subjects into Th17 cells could not be achieved. These findings were extrapolated to suggest that mice are of limited use as models for the development of such cells in the immune system. 54 More recently, however, three independent studies showed that, in contrast to the previous observations, even the differentiation of human Th17 cells requires the activity of TGF-β. [55] [56] [57] All the three reports suggested that in previous studies performed in humans the role of TGF-β had been under evaluated because CD4+ T cells were cultured in media comprising of human or bovine serum, which usually contains TGF-β. The new findings arose new enthusiasm in the community of "mouse" immunologists, 58 because the possibility of a completely different development between murine and human Th17 cells was certainly unfortunate to the biomedical research community, as it is essential to have preclinical data obtained from in vitro and in vivo mouse models before progressing to clinical trials in humans. However, the results of these latter studies are somehow contradictory. Manel et al. 55 found that TGF-β, IL-1 β, and IL-6, IL-21 or IL-23 were necessary and sufficient to induce IL-17 expression in naïve umbilical cord blood (UCB) human CD4+ T 
cells. TGF-β upregulated RORC expression but simultaneously inhibited its ability to induce IL-17
expression, an activity which was antagonized by the inflammatory cytokines. Volpe et al. 56 found that TGF-β, IL-23, IL-1β and IL-6 were all essential for human Th17 differentiation, but they differentially modulated the cytokines produced by Th17 cells. More importantly, the absence of TGF-β induced a shift from the Th17 profile to a Th1-like profile. By contrast, Yang et al. 57 found that TGF-β and IL-21 uniquely promoted the differentiation of human naïve CD4+ T cells into Th17 cells accompanied by expression of RORC.
All human memory Th17 cells express CD161 while murine Th17 cells do not express NK1.1
In the same time, we performed a second study on human Th17, Th1, Th17/Th1 and Th2 clones based on the microarray analysis. The results showed that among genes that were up-regulated in Th17 (or Th17/Th1) in comparison with Th1 or Th2 clones there was CD161. 59 CD161 is the equivalent of murine NK1.1, 60 a molecule which is expressed on the surface of natural killer (NK),
NKT, and on a variable proportion of both CD4+ and CD8+ T cells. IL-17A and IFN-γ production was then evaluated by flow cytometry on CD161+ and CD161-CD4+ T cells from peripheral blood of healthy adult subjects, and virtually all Th17 cells were found to be contained into the CD161+ fraction, whereas Th1 cells could be demonstrated in both the CD161+ and the CD161-fraction. Of note, all CD161+ CD4+ T cells were CD45RA-CD45RO+ (memory) cells, whereas there were virtually no CD161+ cells in the CD45RA+RO-(naïve) population of CD4+ circulating T cells of adult subjects. 59 Accordingly, CD161 expression was found in a remarkable proportion (~20%) of CD3+ cells present in the inflamed skin of patients with psoriasis or the gut mucosa of patients with CD. Virtually no Th17 cells were observed in the CD161-fraction of both peripheral blood of healthy subjects or the inflamed tissues of patients with CD or psoriasis. 59 The possibility that CD161+ Th17 cells were NKT cells, that are also able to produce IL-17A, 61, 62 was excluded by the observation that they had a broad T-cell receptor (TCR) repertoire and the restriction molecule used in antigen recognition was MHC class II, 59 whereas NKT cells are known to have a limited TCR Therefore, two independent studies in humans have demonstrated that all memory Th17 cells are contained into the CD161+ fraction. 59, 64 thus identifying CD161 as a second marker (besides CCR6) of Th17 cells, a feature that has never been reported in mice.
Human Th17 cells exclusively originate from CD161+ T-cell precursors
The However, it is of note that in a very recent report it has been shown that IL-1 signaling is required for early murine Th17 differentiation, which can occur in the absence of exogenous TGF-β, 67 suggesting that even in mice IL-1 is a critical cytokine for Th17 differentiation, whereas the addition of exogenous TGF-β may not be required. 67 
UCB CD4+CD161+ cells that give origin to Th17 cells are naïve T cells
The demonstration that human Th17 cells not only express CD161, but also that they can exclusively originate from naïve CD4+CD161+ T-cell precursors was intriguing. Our results were in agreement with those previously reported by van Beelen et al., 53 who were unable to induce the development of Th17 cells from purified CD45RA+CD45RO-(naïve) circulating CD4+ T cells of adult subjects in response to TGF-β plus IL-6 or IL-1 plus IL-23, 59 a finding which is consistent with the apparent lack of CD161+ cells within the CD45RA+CD45RO-population of adult circulating CD4+ T cells (see also above). The possibility that UCB CD161+ cells giving rise to Th17 cells represent the expansion of a small population of contaminating memory T cells due to fetal immune system stimulation during pregnancy can be reasonably excluded on the basis of three main observations. First, neither CD161+ nor CD161-UBC CD4+ T cells produced any cytokine in response to stimulation with PMA plus ionomycin, except IL-2, which is a functional property of naive T cells. 59 Second, both CD161+ and CD161-cells showed comparable levels of T-cell proliferation. This finding may be in keeping with the observation that 66 human Th17 clones express significantly lower levels of mRNA for clusterin (a pro-apoptotic molecule) and significantly higher levels of mRNA for Bcl-2 (an anti-apoptotic molecule). 66 Moreover, human
Th17 cells appeared to be much less susceptible than Th1 cells to the pro-apoptotic activity of TGF-β, which may account for the different effect of TGF-β on the growth of Th1 and Th17 cells. 
Th17 cells: teachings and future perspectives
The story of Th17 cells is still complex and controversial, but some major teachings seem to be worthy of mention.
Th17 cells exhibit plasticity and can shift to Th1 cells in both humans and mice
As often occurs in immunology, after Th17 cells were discovered in mice as a novel subset of effector T cells and found to be responsible for all inflammatory damages previously attributed to Th1 cells in murine models of autoimmunity, this new dogma was immediately extrapolated to human autoimmune, as well as to all other chronic inflammatory, disorders and the role of Th1 cells was rapidly changed from pathogenic to protective. However, when the properties of Th17 cells were directly investigated in humans, it appeared that these cells are not an established, but rather a flexible, population that can be induced to produce IFN-γ. 33 Although this finding, being in contrast with the new dogma established in mice, was underscored and rarely mentioned in the current literature, the Th17 plasticity to Th1 cells has now been recognized even in murine Th17 cells, 48 For personal use only. on April 30, 2017 . by guest www.bloodjournal.org From where it seems to be even obligatory for the induction of tissue damage. 50, 51 Thus, the first teaching from the Th17 story is that the initial extrapolation of the results obtained in mice to humans was only partially right and that the different results obtained in humans, which suggested the Th17 plasticity to Th1 cells, 59 was true and it has now been confirmed in mice. [48] [49] [50] [51] Thus, we can say that murine Th17 cells can be considered as similar to human Th17 cells, whereas it was not right to consider human Th17 cells equivalent to murine Th17 cells, at least as these latter were initially described.
Human and murine Th17 cells seem to have a different cell origin
The second teaching is that murine and human precursors cannot be found in adult peripheral blood, 53, 59 but they are present as CD161+ RORC+ IL-23R+ CCR6+ cells in both UCB and thymus. 59 
Studies in humans have been critical for dissecting the features and origin of Th17 cells
All these findings allow to suggest a final major teaching that has also been proposed in a recent article, 73 where it was stressed that "although the mouse model has been spectacularly successful in advancing our understanding of basic immunological mechanisms its record in formulating clinically useful protocols is much less impressive. Thus to fully realize the potential benefits of immunology for human health, we need to place more emphasis on human studies and make greater efforts to allow it to flourish". 73 The field of Th17 cells seems to be one of the clearest examples of how studies in humans are critical for dissecting the behaviour and origin of this cell subset. They cannot be therefore disregarded or under evaluated, because they seem to be very useful for correcting wrong views derived from murine models or even for opening completely new avenues. . 59 These cells differentiate in vitro in response to the combined activity of IL-1β and IL-23 into mature Th17 cells, which express RORC, T-bet, IL-12Rβ2, CD161 59 and CCR6, 32, 33 but under the same conditions can also give rise to Th17/Th1 and Th1 cells, which express T-bet 33 and CXCR3. 32, 65 In presence of IL-12, T-bet expression is up-regulated in Th17 cells, which shift to the production of IFN-γ. 33 Murine Th17 cells originate from a naïve Th cell in response to the combined activity of TGF-β and 
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